NOI
RVMD icon

Newton One Investments’s Revolution Medicines RVMD Stock Holding History

Newton One Investments’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7K Hold
100
– – ﹤0.01% 96
2026
Q1 		$9.72K Hold
100
– – ﹤0.01% 102
2025
Q4 		$7.96K Hold
100
– – ﹤0.01% 104
2025
Q3 		$4.67K Hold
100
– – ﹤0.01% 107
2025
Q2 		$3.68K Hold
100
– – ﹤0.01% 113
2025
Q1 		$3.54K Hold
100
– – ﹤0.01% 108
2024
Q4 		$4.37K Buy
+100
New +$5.05K ﹤0.01% 109

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Newton One Investments's RVMD Position: Q2 2026 in Review

Newton One Investments held its Revolution Medicines (RVMD) position steady in Q2 2026 at 100 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #96.

Newton One Investments first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Newton One Investments held 100 shares of Revolution Medicines worth $18.7K as of Q2 2026.
  • Newton One Investments left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Newton One Investments's portfolio in Q2 2026, its #96 holding.
  • Newton One Investments first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Newton One Investments's 13F filing for Q2 2026, filed 22 Jul 2026.